The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Subscription to raise £225,000

19 Sep 2013 07:00

RNS Number : 3577O
Falanx Group Limited
19 September 2013
 

 

19 September 2013

FALANX GROUP LIMITED

("Falanx" or the 'Company')

 

Subscription to raise £225,000

 

 

Falanx Group Limited, a security and risk management consultancy working with blue chip and government clients worldwide, announces that it has conditionally raised £225,000 through a subscription (the "Subscription") of 1,875,000 ordinary shares of no par value.

 

Proceeds of the subscription will be applied to potential acquisition due diligence and general working capital requirements

 

In addition to the Subscription Shares the Company will issue one warrant for every two Placing Shares subscribed, exercisable at 18p per warrant at any time up to three years from issue.

 

Following the issue of the shares Mr Simon Vaughan will hold 4.78% of the enlarged issued share capital and total voting rights.

 

The Subscription is conditional on admission of the Subscription Shares to trading on AIM. The Subscription Shares will rank pari passu with the existing issued ordinary shares of the Company ("Ordinary Shares").

 

Application has been made to AIM for the Subscription Shares to be admitted to trading. Admission and trading in the Subscription Shares are expected to commence on 24 September 2013.

 

On admission of the 1,875,000 Subscription Shares, the Company will have 39,333,333 Ordinary Shares in issue in total.

 

John Blamire, CEO of Falanx, commented:

 

"Admission to AIM has given the Company the boost we expected and as stated we are looking to grow rapidly. These additional funds, raised at the Placing price, will allow us to fund the expansion of the current business and also pay for the due diligence on a number of potential acquisitions."

 

 

 

Falanx Group Limited

John Blamire, Chief Executive

Tel: 020 7856 9457

www.falanxgroup.com

 

Peterhouse Corporate Finance

Jon Levinson/ Lucy Williams

Tel: 020 7469 0930

 

ZAI Corporate Finance Limited

Marc Cramsie

Tel: 020 7060 2220

 

Lothbury Financial Services

Michael Padley/Gary Middleton

Tel: 020 3440 7620

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLPMATMBABBJJ
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.